Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dayle Houston

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Interventions|August 12, 2008
1971-1980Dayle Houston
Molecular Interventions|July 5, 2007
ASPET celebrates its centennial anniversary: 1911-1920Dayle Houston
Molecular Interventions|September 11, 2007
1921-1930Dayle Houston
Molecular Interventions|October 3, 2008
ASPET celebrates its centennial anniversary. 1981-1990Dayle Houston
Combinatorial Chemistry & High Throughput Screening|August 5, 2008
Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptorDayle Houston, Stefano Costanzi, Kenneth A Jacobson, et al.
British Journal of Pharmacology|November 22, 2005
[32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptorsDayle Houston, Michihiro Ohno, Robert A Nicholas, et al.
The Journal of Biological Chemistry|April 2, 2003
Regulation of Ste7 ubiquitination by Ste11 phosphorylation and the Skp1-Cullin-F-box complexYuqi Wang, Qing Ge, Dayle Houston, et al.
British Journal of Pharmacology|November 27, 2010
Ser352 and Ser354 in the carboxyl terminus of the human P2Y(1) receptor are required for agonist-promoted phosphorylation and internalization in MDCK cellsAi-Dong Qi, Dayle Houston-Cohen, Isabella Naruszewicz, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Interventions|August 12, 2008
1971-1980Dayle Houston
Molecular Interventions|July 5, 2007
ASPET celebrates its centennial anniversary: 1911-1920Dayle Houston
Molecular Interventions|September 11, 2007
1921-1930Dayle Houston
Molecular Interventions|October 3, 2008
ASPET celebrates its centennial anniversary. 1981-1990Dayle Houston
Combinatorial Chemistry & High Throughput Screening|August 5, 2008
Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptorDayle Houston, Stefano Costanzi, Kenneth A Jacobson, et al.
British Journal of Pharmacology|November 22, 2005
[32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptorsDayle Houston, Michihiro Ohno, Robert A Nicholas, et al.
The Journal of Biological Chemistry|April 2, 2003
Regulation of Ste7 ubiquitination by Ste11 phosphorylation and the Skp1-Cullin-F-box complexYuqi Wang, Qing Ge, Dayle Houston, et al.
British Journal of Pharmacology|November 27, 2010
Ser352 and Ser354 in the carboxyl terminus of the human P2Y(1) receptor are required for agonist-promoted phosphorylation and internalization in MDCK cellsAi-Dong Qi, Dayle Houston-Cohen, Isabella Naruszewicz, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Pageof 1